AccueilGroupesDiscussionsPlusTendances
Site de recherche
Ce site utilise des cookies pour fournir nos services, optimiser les performances, pour les analyses, et (si vous n'êtes pas connecté) pour les publicités. En utilisant Librarything, vous reconnaissez avoir lu et compris nos conditions générales d'utilisation et de services. Votre utilisation du site et de ses services vaut acceptation de ces conditions et termes.

Résultats trouvés sur Google Books

Cliquer sur une vignette pour aller sur Google Books.

Chargement...

The Billion Dollar Molecule: One Company's Quest for the Perfect Drug

par Barry Werth

MembresCritiquesPopularitéÉvaluation moyenneMentions
1563174,953 (4.07)3
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.… (plus d'informations)
Chargement...

Inscrivez-vous à LibraryThing pour découvrir si vous aimerez ce livre

Actuellement, il n'y a pas de discussions au sujet de ce livre.

» Voir aussi les 3 mentions

3 sur 3
Way too much nitty gritty detail for a lay reader. If you were involved in this company or a scientist you might enjoy it more than I did. ( )
  BrendaRT20 | Sep 3, 2023 |
Werth's book about a company's inception and its revolutionary use of rational drug design should be required reading for all in the sciences. It highlights to amazing extents the pros and cons of academia and industry, and as a current PhD student, I can fully relate to the issues. The scientific struggles of publishing and politics are all excruciatingly detailed, and you're left in awe of the immense strength and will of the characters. Werth's prose is riveting as well. I wish there were a more recent book of equal calibre, detailing maybe a company's trials in genomic medicine. ( )
  bsmashers | Aug 1, 2020 |
A very interesting story of a pharmaceutical startup. So much hype, with no solid basis, and yet they survive. Werth does a good job explaining the business, the science, and the experience of doing the science.

> Scientists, unlike, say, athletes, conjure their own competition. They seldom know precisely whom they’re competing with or where they are in the race. They hear things—rumors, reports—but the information comes at a distance and with a price: It may be exaggerated, deliberately misleading, or simply false. The atmosphere in a lab in the throes of a heated project is insular, secretive, xenophobic, superheated, and paranoid.

> "There's two situations where you want to be aggressive about publishing. One is when you're behind; the other is when you're ahead. When you're ahead, you demoralize the other guy. When you're behind, you have nothing to lose. It's when you don't know that you want to be most careful." ( )
  breic | Aug 2, 2019 |
3 sur 3
aucune critique | ajouter une critique
Vous devez vous identifier pour modifier le Partage des connaissances.
Pour plus d'aide, voir la page Aide sur le Partage des connaissances [en anglais].
Titre canonique
Titre original
Titres alternatifs
Date de première publication
Personnes ou personnages
Lieux importants
Évènements importants
Films connexes
Épigraphe
Dédicace
Premiers mots
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
Squatting between the twin towers of the World Trade Center in New York City, the Vista International Hotel is a minor cultural monument of the 1980s.
Citations
Derniers mots
Informations provenant du Partage des connaissances anglais. Modifiez pour passer à votre langue.
(Cliquez pour voir. Attention : peut vendre la mèche.)
Notice de désambigüisation
Directeur de publication
Courtes éloges de critiques
Langue d'origine
DDC/MDS canonique
LCC canonique

Références à cette œuvre sur des ressources externes.

Wikipédia en anglais (2)

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing -- atom by atom -- both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Aucune description trouvée dans une bibliothèque

Description du livre
Résumé sous forme de haïku

Discussion en cours

Aucun

Couvertures populaires

Vos raccourcis

Évaluation

Moyenne: (4.07)
0.5
1
1.5
2 1
2.5 1
3
3.5 1
4 7
4.5
5 5

Est-ce vous ?

Devenez un(e) auteur LibraryThing.

 

À propos | Contact | LibraryThing.com | Respect de la vie privée et règles d'utilisation | Aide/FAQ | Blog | Boutique | APIs | TinyCat | Bibliothèques historiques | Critiques en avant-première | Partage des connaissances | 204,715,246 livres! | Barre supérieure: Toujours visible